ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR was delisted on the 27th of May, 2025.
13 hedge funds and large institutions have $7.84M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
38% more capital invested
Capital invested by funds: $5.7M → $7.84M (+$2.14M)
18% more funds holding
Funds holding: 11 → 13 (+2)
2.1% more ownership
Funds ownership: 15.46% → 17.56% (+2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$430K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$320K |
| 3 |
LPL Financial
San Diego,
California
|
+$258K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$215K |
| 5 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$38.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$246K |
| 2 |
RPG
Risk Paradigm Group
Austin,
Texas
|
-$16.1K |
| 3 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
-$4.62K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BL
1
BCWM LLC
Overland Park,
Kansas
| $4.41M | +$15.1K | +620 | +0.4% |
|
|
2
Jane Street
New York
| $1.18M | +$430K | +17,661 | +68% |
|
|
3
LPL Financial
San Diego,
California
| $848K | +$258K | +10,619 | +51% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $360K | -$246K | -10,100 | -43% |
|
|
5
Bank of Montreal
Toronto,
Ontario, Canada
| $356K | +$320K | +13,172 | New |
|
|
SG
6
StoneX Group
New York
| $339K | +$15.5K | +638 | +5% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $239K | +$215K | +8,821 | New |
|
|
WAP
8
Wealthcare Advisory Partners
West Chester,
Pennsylvania
| $43K | +$38.9K | +1,600 | New |
|
|
BBPWM
9
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $27K | -$4.62K | -190 | -16% |
|
|
GT
10
Glenmede Trust
Philadelphia,
Pennsylvania
| $18K | – | – | – |
|
|
AG
11
Advisor Group
Phoenix,
Arizona
| $17K | – | – | – |
|
12
Fifth Third Bancorp
Cincinnati,
Ohio
| $8K | +$4.86K | +200 | +200% |
|
|
LTFS
13
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | – | – | – |
|
|
RPG
14
Risk Paradigm Group
Austin,
Texas
| – | -$16.1K | -700 | Closed |
|
CNCR Hedge Fund Activity: Q3 2017 in Review
13 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) for Q3 2017, worth a combined $7.84M — up 38% from $5.7M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CNCR positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, adding an estimated $430K. The largest seller was Royal Bank of Canada, cutting an estimated $246K.
- 13 institutional investors held ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) as of Q3 2017, up from 11 in Q2 2017.
- Funds reported $7.84M of ETF Series Solutions Trust Range Cancer Therapeutics ETF stock for Q3 2017, up 38% quarter-over-quarter.
- 3 funds opened new ETF Series Solutions Trust Range Cancer Therapeutics ETF positions in Q3 2017 and 1 closed out, a net change of +2 holders.
- The largest ETF Series Solutions Trust Range Cancer Therapeutics ETF buyer in Q3 2017 was Jane Street, an estimated $430K added.
- The largest ETF Series Solutions Trust Range Cancer Therapeutics ETF seller in Q3 2017 was Royal Bank of Canada, an estimated $246K sold.
Based on aggregated 13F filings for Q3 2017.